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Abstract 
 
Study Objectives: We examined cross-sectional and prospective associations 
between sleep debt and adiposity measures, as well as homeostatic model assessment-
insulin resistance (HOMA-IR) in early type 2 diabetes. 
Methods: Prospective data analysis from participants of a randomized controlled trial 
based on an intensive lifestyle intervention (usual care, diet, or diet and physical 
activity). Data were collected at baseline, 6 months, and 12 months post-intervention. 
The study was performed across five secondary care centers in the United Kingdom. 
Patients (n = 593) with a recent diagnosis of type 2 diabetes were recruited. Objective 
height and weight were ascertained for obesity status (body mass index [BMI]; ≥30 
kg/m2), waist circumference (cm) for central adiposity, and fasting blood samples 
drawn to examine insulin resistance. Seven-day sleep diaries were used to calculate 
weekday sleep debt at baseline, calculated as average weekend sleep duration minus 
average weekday sleep duration.  
Results: At baseline, compared to those without weekday sleep debt, those with 
weekday sleep debt were 72% more likely to be obese (OR = 1.72 [95%CI:1.03-
2.88]). At six months, weekday sleep debt was significantly associated with obesity 
and IR after adjustment, OR = 1.90 (95%CI:1.10-3.30), OR = 2.07 (95%CI:1.02-
4.22), respectively. A further increase at 12 months was observed for sleep debt with 
obesity and IR: OR = 2.10 (95%CI:1.14-3.87), OR = 3.16 (95%CI:1.38-7.24), 
respectively. For every 30 minutes of weekday sleep debt, the risk of obesity and IR 
at 12 months increased by 18% and 41%, respectively.  
Conclusions: Sleep debt resulted in long-term metabolic disruption, which may 
promote the progression of type 2 diabetes in newly diagnosed patients. Sleep 
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hygiene/ education could be an important factor for future interventions to target early 
diabetes. 
Keywords: insulin resistance, type 2 diabetes mellitus, sleep debt, obesity, body mass 
index, waist circumference, central adiposity 
 
Current Knowledge/Study Rationale: Sleep loss has been attributed to diabetes 
onset and progression, but little is known about the chronic effect of weekday sleep 
debt, which is common in contemporary society, upon diabetes outcomes in those 
with a recent diagnosis. Our study was performed to assess the long-term impact of 
weekday sleep debt upon multiple common, yet modifiable, diabetes outcomes 
(obesity, insulin sensitivity and central adiposity) in newly diagnosed type 2 diabetes 
mellitus patients. 
Study Impact: Our findings highlight the importance of improving sleep in those 
with a new diagnosis of type 2 diabetes mellitus. Avoiding accumulation of sleep debt 
on weekdays may be a key component for minimizing adverse outcomes associated 
with diabetes mellitus (obesity, insulin resistance, and excess central adiposity), 
which could be incorporated into the future clinical management of this patient 
population. 
Introduction 
The International Diabetes Federation recently estimated that globally over 
382 million individuals had diabetes in 2013 (an estimated 46.3% undiagnosed) and 
that this number is expected to rise to 592 million by 2035.1 The majority of affected 
individuals (over 90%) have type 2 diabetes, which is closely related to excess 
adiposity and its associated lifestyle factors such as poor diet and low physical 
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activity. Sleep (duration and quality) may be another important factor associated with 
both obesity and type 2 diabetes, as suggested by both population and experimental 
studies.2-6 It has been hypothesized that social and work demands increasingly result 
in shorter sleep duration than required physiologically.7 This sleep loss, accumulated 
into a sleep debt during weekdays, may be partially repaid by extra sleep on 
weekends. Sleep debt is particularly evident in shift-workers and has been linked with 
metabolic disruption including increased secretion of cortisol, and higher C-reactive 
protein, triglycerides and low-density lipoprotein cholesterol levels.8,9 Persistent sleep 
debt may therefore play a role in promoting the onset/ progression of chronic 
metabolic disease. While insufficient sleep, which results in sleep debt, and sleep 
disruption are associated with a potential increased risk for diabetes,10 little is known 
about the impact of weekday sleep debt once diabetes is present. We therefore 
investigated the relationship between sleep debt, and obesity, central adiposity, and 
insulin resistance in a well-characterized group of patients with early type 2 diabetes. 
We hypothesized that there would be a relationship between weekday sleep debt and 
three key features of type 2 diabetes mellitus: obesity, central adiposity, and insulin 
resistance. 
METHODS 
Data were from the Early ACTivity In Diabetes (Early ACTID) randomized 
controlled trial (Trial register ISRCTN92162869), which has been previously 
described.11 Briefly, participants aged 30-80 years with newly diagnosed type 2 
diabetes mellitus (diagnosed within 5-8 months prior to participation) were recruited 
from primary care and randomly allocated to receive either lifestyle intervention 
(dietary modification or dietary modification plus additional physical activity) or 
usual care. Participants were excluded if they fulfilled one or more of the following 
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criteria: older than 80 years, HbA1c concentration >10%, blood pressure >180/100 
mm Hg, LDL cholesterol concentration >4 mmol/L, body mass index (BMI) <25 
kg/m2, body weight >180 kg, use of weight-loss drugs, taking a sulphonylurea at the 
maximum dose, unstable angina, a myocardial infarction 3 months prior to 
participation, inability to increase physical activity, pregnancy/ planning pregnancy. A 
total of 593 participants were recruited and underwent a detailed assessment, 
including medical history and a physical examination. Participants were randomized 
according to computer-generated allocation and were assigned using a 2:5:5 ratio 
(usual care: intensive diet intervention: intensive diet intervention plus activity). A 7-
day sleep diary and a sleep questionnaire, previously employed in a well-established 
sleep cohort,12 were administered prior to commencement of the intervention. Follow-
up data were obtained at 6 and 12 months post-intervention for all participants. The 
study received ethical approval from the Bath Hospital Research Ethics Committee 
and all participants provided written informed consent (05 /Q 2001 /5). 
Sleep Measures 
Weekday sleep duration was derived from the 7-day sleep diary by calculating 
the difference between the estimated time of sleep onset and sleep offset (wake). 
Average weekday sleep duration was then calculated by adding sleep duration from 
Sunday through to Thursday and dividing by 5.13 Similarly, average weekend sleep 
duration was derived in the same manner by adding sleep duration for Friday and 
Saturday and dividing by 2.13 We then derived weekday sleep debt (average weekend 
sleep duration minus average weekday sleep duration). Participants were also asked to 
complete 7-day sleep diaries at 6 and 12 months post-intervention. 
From the sleep questionnaire (see Supplemental File 1), we acquired 
information about sleep problems (physician diagnosed OSA/ snoring/ other/ none). 
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We also collected data regarding shift-work with response options of yes/ no to the 
question “I have a job that involves shift-work or night work” and considered this as a 
potential confounder in our analyses. 
Obesity and Central Adiposity  
 
Height (cm) was obtained objectively at baseline and body weight (kg) was 
ascertained and recorded for all participants at baseline and then at 6 and 12 months 
post-intervention. These measures were used to derive BMI. Overweight/ obesity 
status was considered as BMI ≥30 kg/m2. Waist circumference (cm) was measured in 
participants at each of the 3 visits (baseline and 6 and 12 months post-intervention). 
Participants were requested to stand with feet shoulder-width apart, and a measuring 
tape was passed horizontally around the center of the iliac crest to obtain the 
measurement, which was conducted and recorded by a trained nurse. As a measure of 
central adiposity, we used sex-specific cut points based on the National Institute of 
Health, where >88 cm (women) and >102 cm were considered as excess central 
adiposity.14 
Diabetes Outcomes 
 
Participants presented to the research center at the 3 time points (baseline, 6 
months, and 12 months post-intervention) following an overnight fast. A blood 
sample was drawn for assessment of glucose and insulin using standard assays to 
determine insulin resistance, using a standardized technique (homeostatic model 
assessment-insulin resistance)15 at baseline, 6 months, and 12 months post-
intervention. Furthermore, we also measured hemoglobin A1c percent (HbA1c %) 
from the overnight fasted blood sample as a measure of diabetes control.  
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Other Measures 
We obtained demographic information (age, gender), which we considered as 
potential confounders in our multivariate analyses. Physical activity levels were 
assessed across a 7-day period using a waist-worn accelerometer (GT1M; ActiGraph 
LLC, Pensacola, FL, USA). Participants were instructed to wear the device on 
awakening and remove at bedtime. Data were downloaded from the device using the 
manufacturer’s software and the average counts per minute (cpm) were derived from 
all days that the monitor was worn.16 We also ascertained information relating to 
medication use at each of the 3 time points, including lipid-reducing medication (yes/ 
no), blood pressure lowering medication (yes/ no) and number of medications for 
diabetes mellitus (DM). None of the participants were on insulin on recruitment into 
the study, and there was no significant change in DM medication 6 months post-
intervention. The proportion of participants taking DM medication 12 months post-
intervention increased in all conditions, and 2 participants became insulin-treated. We 
considered medication use of any type as a potential confounder in our analyses. 
Statistical Analysis 
All statistical analyses were performed using Stata version 13 (Texas, USA). 
Continuous data were checked for normality of distribution by visual inspection, prior 
to conducting statistical tests. First, we conducted a series of independent t-tests, χ2 or 
Wilcoxon signed ranks test, as appropriate, to compare those with zero or negative 
weekday sleep debt to those with positive weekday sleep debt in a number of baseline 
characteristics. Secondly, we investigated the potential relationships, using 
multivariate logistic regression, comparing those with baseline weekday sleep debt to 
those with zero/ negative weekday sleep debt (referent). Four dependent variables 
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were considered in our analyses. Firstly, we dichotomized BMI to determine obesity 
status where <30 kg/m2 (overweight/non-obese) was considered as the referent and 
compared with obesity (BMI ≥30 kg/m2). Secondly, we considered excess central 
adiposity using sex-specific cut points for waist circumference based on the National 
Institute of Health recommendations.14 Thirdly, we dichotomized HOMA-IR 
comparing ≤2.5 as the referent, with >2.5 indicating insulin resistance.17,18 Finally, we 
dichotomized HbA1c% using standardized cut points (<6.5% as the referent versus 
≥6.5%). Each of the outcome variables was assessed at baseline, 6 months, and 12 
months post-intervention. In our series of multivariate logistic regression analyses, we 
present Model 1 (univariate) and then first adjusted for age and gender, as appropriate 
(Model 2); we then further adjusted for medications (lipids, blood pressure, diabetes 
mellitus), sleep dysfunction, shift-work, physical activity (counts per minute), change 
from baseline to study time point assessed in BMI, waist circumference HOMA-IR 
and HbA1c (as appropriate), as well as intervention type (usual care [referent], diet, 
diet and physical activity), at 6 and 12 months post-intervention only. We further 
adjusted for BMI in Model 3 for the outcomes: waist circumference, insulin 
resistance, and HbA1c. To further examine the effect of weekday sleep debt, we then 
repeated our multivariate logistic regression, to assess the effect size for every 30 
minutes of weekday sleep debt in relation to obesity, central adiposity, insulin 
resistance, and HbA1c. The odds ratios (OR) and 95% confidence intervals (95% CIs) 
are reported for all analyses. We performed a one-way ANOVA with post hoc 
Bonferroni tests to assess potential mean differences between weekday and weekend 
sleep duration at each of the 3 time points assessed according to randomized condition 
(usual care, diet, or diet and physical activity intervention). 
RESULTS 
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Complete information on all variables of interest was available in 365 newly 
diagnosed type 2 diabetes mellitus patients. The baseline characteristics of the sample, 
according to the presence/ absence of weekday sleep debt, are presented in Table 1. 
Of the total sample, 61% (n = 221) reported positive weekday sleep debt, where the 
mean was 46 minutes (95% CI: 40, 53). On average those without weekday sleep debt 
reported -40 minutes’ discrepancy between weekend and weekday sleep duration 
(95% CI: -46, -34).  Briefly, compared to those with no weekday sleep debt, those 
with a weekday sleep deficit had significantly higher BMI (p = 0.014), body weight 
(p= 0.031), weekday and weekend sleep duration (p = 0.002 and p < 0.001), sleep 
dysfunction (p< 0.001), waist circumference (p = 0.003), and HOMA-IR (p = 0.005). 
There was no significant difference in the number of diabetes mellitus medications 
across the 3 time points assessed (p = 0.109) for the total sample. Differences in the 
percentage of participants with obesity, excess central adiposity, insulin resistance 
and HbA1c ≥6.5% according to the presence or absence of weekday sleep debt are 
presented in Figure 1A-D, respectively.   
There was a cross-sectional relationship between positive weekday sleep debt 
and obesity, after adjustment OR = 1.72 (95% CI: 1.02-1.92). Longitudinal 
multivariate analyses demonstrated a significant, increased risk of obesity at 6 months 
and a further increase at 12 months post-intervention with positive weekday sleep 
debt at baseline (see Table 2). The strongest effect of weekday sleep debt at baseline 
was observed for obesity at 12 months post-intervention OR = 2.10 (95% CI: 1.14-
3.87), after adjustment. 
We observed a significant cross-sectional association between weekday sleep 
debt and waist circumference OR = 1.87 (95% CI: 1.10-3.17), adjusted for age, 
although this relationship diminished with further adjustment (see Table 2). After full 
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adjustment, a significant association was present between weekday sleep debt and 
central adiposity at 6 months only, OR = 1.99 (95% CI: 1.14-3.48).  
No cross-sectional relationship was observed between positive weekday sleep 
debt at baseline and insulin resistance, before or after adjustment (see Table 2). There 
was, however, a significant increased risk of insulin resistance, after adjustment, at 6 
months and 12 months post-intervention in those with positive weekday sleep debt. At 
6 months post-intervention, individuals with a positive weekday sleep debt at baseline 
were more than 2 times more likely to be insulin resistant. At 12 months post-
intervention, compared to those without weekday sleep debt at baseline, those with 
sleep debt were more than 3 times more likely to be insulin resistant.  
Those with weekday sleep debt had a significantly increased risk of HbA1c 
≥6.5% at baseline (OR = 1.85 [95% CI: 1.08-3.14]) and 6 months post-intervention 
(OR = 1.95 [95% CI: 1.12-3.40]). No association was found at 12 months post-
intervention between baseline weekday sleep debt and HbA1c ≥6.5%. 
For every 30 minutes of additional weekday sleep debt at baseline, the risk of 
obesity and insulin resistance cross-sectionally showed no significant associations. A 
positive risk for obesity and insulin resistance, however, were observed longitudinally 
at 6 months post-intervention. Each additional 30 minutes of weekday sleep debt at 
baseline was associated with an 18% increased risk of excess central adiposity at 
baseline. Six months post-intervention, 30 minutes of weekday sleep debt was 
significantly associated with an increased risk of all 3 outcomes: 15% for obesity, 
24% for insulin resistance, and 23% for central adiposity. A further significant 
increase was present at 12 months post-intervention for both obesity (18%) and 
insulin resistance (41%) (Table 3). Baseline weekday sleep debt of 30 minutes was 
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associated with HbA1c ≥6.5% at 6 months post-intervention only (OR = 1.18 [95% 
CI: 1.03-1.36]).  
No differences were observed for average weekday or weekend sleep duration 
at any of the 3 study time points according to the randomized condition (p > 0.05). 
The only exception was weekday sleep duration for those randomized to usual care 
(8.2±1.0 hours) compared to the diet intervention (7.7±1.1 hours) at 12 months post-
intervention, where the post-hoc Bonferroni test was p = 0.020. 
DISCUSSION 
Our study investigated the potential cross-sectional and prospective impact of 
weekday sleep debt upon obesity and insulin resistance in a large cohort of newly 
diagnosed patients with type 2 diabetes mellitus. Our findings demonstrate an 
increasing risk of obesity over the three time points assessed in those with positive 
weekday sleep debt at baseline. The effect of weekday sleep debt at baseline was also 
significantly and prospectively associated with central adiposity, increased insulin 
resistance, as well as glycemic control. Intervention type did not alter these 
associations (p > 0.05 for both intervention arms). We observed a small amount of 
weekday sleep debt, as little as 30 minutes, to be important for prospectively 
increasing the risk of all three common features in early type 2 diabetes mellitus 
patients.  
Previous studies have examined the impact of shorter sleep duration on body 
composition and metabolic parameters.6,19,20 It has been hypothesized that sleep loss 
predisposes to excess adiposity and metabolic derangements such as insulin 
resistance.6,10,20 Sleep loss is usually accumulated on weekdays, being associated with 
work and social commitments, with an opportunity to repay the accumulated sleep 
debt on weekend days.  Few previous studies have examined the impact of sleep debt 
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on body composition and insulin resistance. Specifically, there are no studies 
examining the impact of sleep debt in patients with early diabetes.  
Previous studies have shown that sleep loss is accumulated, creating a greater 
sleep debt, with potential downstream effects on sleepiness and cognition.21,22 In one 
study, the greater sleep debt accumulated through chronic partial sleep deprivation in 
healthy volunteers (14 nights of 4 h or 6 h of sleep opportunity versus 8 h), the more 
impeded the participant’s cognitive performance.21 Thus, if sleep loss accumulates, 
resulting in a sleep debt that is not repaid, then neurobehavioral consequences ensue. 
Our findings now show that sleep debt also has a significant impact on body 
composition and metabolic health. 
There has been an important focus on the link between short sleep duration 
and metabolic disease in recent decades with systematic reviews and meta-analyses 
demonstrating strong associations with obesity (odds ratio = 1.55),23 waist 
circumference (r = -0.10),24 and type 2 diabetes mellitus (relative risk = 1.28).25 
Previous studies, however, have concentrated on the impact of extremes of sleep 
duration (e.g., <5 h of sleep/night), but few studies have examined the cumulative 
effect of smaller degrees of sleep loss. We have shown that as little as 30 minutes of 
weekday sleep debt may contribute to the development and/ or progression of obesity, 
central adiposity, and insulin resistance over time in patients with early diabetes. 
Furthermore, given our prospective analysis, sleep debt over time is likely to have a 
longer-term dose-dependent effect on body composition and insulin resistance. Sleep 
debt at baseline, for example, was associated with increased insulin resistance at 12 
months by almost three-fold. 
The mechanisms for the impact of sleep debt on body composition and 
metabolism remain to be determined. However, previous population and human sleep 
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laboratory studies of healthy volunteers have highlighted several potential pathways. 
These include alterations in hormones regulating appetite, energy expenditure, and 
glucose homeostasis such as ghrelin, leptin, cortisol, and growth hormone.6,22 An 
early report by Spiegel and colleagues, subjected 11 healthy, young male participants 
to 3 nights of 8 hours of sleep opportunity (baseline) and then 6 nights of 4 hours’ 
time in bed (sleep debt condition), and finally 7 nights of 12 hours in bed (sleep 
recovery). This study highlighted the impact of sleep deprivation on glucose 
homeostasis (reduced glucose tolerance) and cortisol secretion (elevated evening 
cortisol levels). Similar findings were observed for subjective sleepiness and 
sympatho-vagal balance (measured objectively by examining beat-to-beat heart-rate 
intervals). The link between sleep (generally believed to be a brain phenomenon) and 
hormone secretion appears to be explained by increased sympathetic activation with 
sleep loss.22 The metabolic alterations with sleep deprivation were reversed during 
sleep recovery suggesting that repayment of sleep debt may normalize some sleep-
related hormone alterations.22 Encouraging sleep debt repayment may be a novel and 
relatively straightforward approach to promoting optimum health and wellbeing. 
Other potential pathways include increased wakefulness and opportunity to eat.26 For 
example, a number of recent experimental studies enforcing sleep reduction that 
results in additional wakefulness, have demonstrated increased food intake/ calorie 
consumption, particularly during evening/ early hours.27-29 One study found the order 
of sleep manipulation to be important with beneficial effects on body weight with 
decreases in the consumption of energy (fats and carbohydrates) in those experiencing 
adequate/ recovery sleep subsequent to sleep loss.27 If this concept is applied to our 
own study findings then energy intake may improve during weekends in those with 
positive weekday sleep debt, although weight gain may still occur given the higher 
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proportion of weekdays to weekends. This, however, requires further investigation in 
future studies to confirm or refute this notion.  
In a six-year prospective study, short sleepers (≤6 hours), as compared to 
those with healthy sleep duration (7-8 hours), increased waist circumference and 
gained more weight over the study period. Statistically significant increases in these 
outcomes were found in individuals who scored high, compared to low for 
disinhibited eating (tendency to overeat and/ or eat opportunistically). Over the six-
year period, the risk of incident overweight/ obesity in short sleepers with high 
disinhibited eating was OR = 4.49 (95% CI: 3.06-6.06).4 The downstream 
physiological impact of persistent short sleep are likely to have consequential effects 
on feeding behaviors that may lead to weight gain and diabetes mellitus onset. Recent 
advances that have explored the relationship between experimental sleep loss, 
appetitive food desire and neuronal activity have revealed potential mechanistic 
pathways. For example, Greer and colleagues demonstrated reduced activity in 
multiple brain regions, known to be instrumental in appetitive desire.30 Participants (n 
= 23) completed a food-desire task (desire for 80 presented food items) and 
underwent fMRI after two sleep conditions (24 hours total sleep deprivation and 
normal rested sleep of ~8 h). Compared to when participants were rested, after total 
sleep deprivation a significant reduction in activity across all three brain regions were 
observed. Moreover, an increase in the desire for unhealthy food types (high in 
calories) after sleep deprivation (T = 2.21, p = 0.04) was observed.30 These recent 
findings are pivotal in elucidating our understanding of how sleep loss is linked to 
energy homeostasis and ultimately lifestyle-driven disease onset/ progression.  
Our study benefitted from a large sample of newly diagnosed type 2 diabetes 
mellitus patients with detailed information concerning medication use and objective 
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measures of metabolic markers. The study also benefitted from consistent dietary and 
physical advice delivered to the intervention groups. A limitation of our study is the 
use of sleep diaries as opposed to more objective measures such as actigraphy. We, 
and others, have, however, previously demonstrated that sleep diary data has a good 
level of agreement with wrist actigraphy and can be an accurate estimate of sleep 
duration.13 Rogers et al. also demonstrated an acceptable agreement level (κ = 0.87) 
with high sensitivity and specificity (92.3% and 95.6%, respectively) between sleep 
duration reported in sleep diaries compared to 24-hour portable polysomnographic 
monitoring in a sleep-disordered patient population as well as healthy controls.31 
However, we also acknowledge that sleep diary data is less accurate compared to 
actigraphy in some patient populations.32 Also, although our study did not objectively 
screen for sleep-disordered breathing; instead, we obtained information using self-
reported physician diagnosed data. Nevertheless, it is possible that the observed 
associations could been confounded by obstructive sleep apnea, given that a 
substantial proportion of sleep apnea cases have been documented in healthy, pre-
diabetes and diabetes populations.33-37 It is possible that the effects of weekday sleep 
debt and/ or other aspects of sleep may be more powerful prior to the onset of 
diabetes mellitus, or even contribute to its development, but we were only able to 
assess the prospective effects of weekday sleep debt subsequent to diabetes diagnoses. 
In conclusion, we report prospective findings in a large sample of newly 
diagnosed type 2 diabetes mellitus patients, demonstrating the impact of sleep debt in 
this population. Increasing evidence shows the importance of tackling type 2 diabetes 
mellitus at the earliest stage possible. Reducing excess adiposity and insulin 
resistance is important for achieving good diabetes outcomes. Our data suggest that 
weekday sleep debt is a potential factor that affects body composition and glucose 
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homeostasis. Thus, addressing this factor may be important in metabolic 
improvement, and could be incorporated into future interventions aimed at tackling 
diabetes. 
 
 
Figure 1: Proportion of individuals with and without sleep debt according to obesity, 
central adiposity, and insulin resistance at each of the three study time points 
(baseline, 6 months, and 12 months post-intervention). (A) percentage of participants 
with obesity at each assessed time point according to presence/ absence of weekday 
sleep debt at baseline; (B) percentage of participants with excess central adiposity at 
each assessed time point according to presence/ absence of weekday sleep debt at 
baseline; (C) percentage of participants with insulin resistance at each assessed time 
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Table 1. Baseline characteristics of 365 newly diagnosed type 2 diabetes mellitus 
patients in the ACTID study, according to weekday sleep debt status 
 
Data are presented as mean ± standard deviation, median (interquartile range) or n 
(%), as appropriate. BMI = body mass index; BP = blood pressure; DM = diabetes 
mellitus; OSA = obstructive sleep apnea; HOMA-IR = homeostatic model 
assessment-insulin resistance; HDL-C = high-density lipoprotein cholesterol. 
*Information only available for 347 participants. Negative sleep debt = zero/ negative 
value (minutes) from the equation (weekend sleep duration minus weekday sleep 
 Negative weekday 
sleep debt 
(n=144) 
Positive weekday 
sleep debt 
(n=221) 
p-value 
Age 64.5±9.0 63.1±9.9 0.229 
Gender   0.251 
  Male 99 (68.8) 139 (62.9)  
  Female 45 (31.2) 82 (37.1)  
BMI kg/m2  29.6 (27.4-32.6) 30.8 (28.0-34.5) 0.014 
Body weight (kg) 
Waist circumference (cm) 
86.3 (76.8-96.7) 
104.0±0.9 
89.8 (81.1-100.5) 
108.0±0.9 
0.031 
0.003 
 
Lipids medication   0.364 
  No 48 (33.3) 84 (38.0)  
  Yes 96 (66.7) 137 (62.0)  
BP medication   0.432 
  No 56 (38.9) 77 (57.9)  
  Yes 88 (61.1) 144 (65.1)  
# DM medication   0.232 
  0 83 (57.6) 139 (62.9)  
  1 56 (38.9) 69 (31.2)  
  2 5 (3.5) 13 (5.9)  
Sleep dysfunction    
  None 138 (95.8) 202 (91.4) <0.001 
  OSA 3 (2.1) 9 (4.1)  
  Snoring 0 (0.0) 4 (1.8)  
  Other 3 (2.1) 6 (2.7)  
Shift worker*    0.287 
  Yes 13 (9.5) 14 (6.7)  
  No 124 (90.5) 196 (93.3)  
Weekday sleep duration 
(hours) 
Weekend sleep duration 
(hours) 
HOMA-IR 
HbA1c (%) 
8.0±1.1 
 
7.4±1.2 
 
4.3 (3.0-6.8) 
6.4 (6.0-7.0) 
7.7±1.1 
 
8.4±1.2 
 
5.4 (3.8-8.0) 
6.5 (6.1-7.1) 
0.002 
 
<0.001 
 
0.005 
0.332 
Intervention 
  Usual care 
  Diet only 
  Diet & physical activity 
 
23 (16.0) 
67 (46.5) 
54 (37.5) 
 
33 (14.9) 
87 (39.4) 
101 (45.7) 
 
0.286 
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duration). Positive weekday sleep debt = positive value (minutes) from the equation 
(weekend sleep duration minus weekday sleep duration). 
 
 
Table 2. The associations between positive weekday sleep debt and adiposity, 
insulin resistance and HbA1c at baseline, 6 months, and 12 months post-
intervention in 365 newly diagnosed type 2 diabetes mellitus patients 
 
Obesity Model 1 
 
Model 2 Model 3 
At baseline 1.73 (1.07-2.81)* 1.73 (1.06-2.81)* 1.72 (1.03-2.88)* 
At 6 months  1.76 (1.08-2.88)* 1.76 (1.07-2.91)* 1.90 (1.10-3.30)* 
At 12 months  2.02 (1.18-3.48)* 2.03 (1.17-3.50)* 2.10 (1.14-3.87)* 
 
Central 
adiposity 
Model 1 Model 2 Model 3 
 
At baseline 1.81 (1.07-3.07)* 1.87 (1.10-3.17)* 1.68 (0.96-2.92) 
At 6 months 1.88 (1.13-3.11)* 1.86 (1.12-3.10)* 1.99 (1.14-3.48)* 
At 12 months 1.91 (1.10-3.31)* 1.90 (1.09-3.30)* 1.84 (1.00-3.40) 
 
Insulin 
resistance 
Model 1 Model 2 Model 3 
At baseline 1.58 (0.69-3.60) 1.60 (0.70-3.65) 1.27 (0.53-3.08) 
At 6 months 2.21 (1.15-4.27)* 2.34 (1.20-4.56)* 2.07 (1.02-4.22)* 
At 12 months 3.28 (1.67-6.44)** 3.58 (1.79-7.18)*** 3.16 (1.38-7.24)** 
    
HbA1c %  Model 1 Model 2 Model 3 
    
At baseline 1.59 (0.98-2.57) 1.55 (0.95-2.52) 1.85 (1.08-3.14)* 
At 6 months 1.69 (1.03-2.78)* 1.69 (1.03-2.78)* 1.95 (1.12-3.40)* 
At 12 months 1.52 (0.90-2.58) 1.49 (0.88-2.54) 1.54 (0.84-2.84) 
    
 
Data are presented as odds ratio (95% confidence interval). 
* p < 0.05; **p < 0.01; ***p < 0.001. 
Model 1: unadjusted; 
Model 2: adjusted for age and gender, as appropriate; 
Model 3: further adjusted for lipid and hypertension medication, number of diabetes 
mellitus medications, sleep dysfunction, physical activity, shift-work, and, BMI and 
intervention type (usual care [referent], diet, diet and physical activity), as 
appropriate. At 6 and 12 months post-intervention, we also adjusted for changes in 
BMI, waist circumference HOMA-IR and HbA1c from baseline to the corresponding 
time point, as appropriate.  
Obesity defined as BMI ≥30kg/m2; central adiposity defined as 88 cm (women), 102 
cm (men); insulin resistance defined as HOMA-IR >2.5; HbA1c (<6.5% versus 
≥6.5%); zero/negative weekday sleep debt served as the referent category. 
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Table 3. The associations between every 30 minutes of positive weekday sleep 
debt and obesity, central adiposity, and insulin resistance at baseline, 6 months, 
and 12 months post-intervention in 365 newly diagnosed type 2 diabetes mellitus 
patients 
 
Obesity Model 1 
 
Model 2 Model 3 
At baseline 
At 6 months 
At 12 months 
1.10 (0.98-1.24) 
1.13 (0.99-1.27) 
1.19 (1.03-1.37)* 
1.10 (0.97-1.24) 
1.12 (0.99-1.27) 
1.18 (1.03-1.36)* 
1.11 (0.98-1.27) 
1.15 (1.01-1.32)* 
1.18 (1.02-1.37)* 
 
Central adiposity Model 1 Model 2 
 
Model 3 
At baseline 1.16 (1.01-1.33)* 1.17 (1.02-1.34)* 1.17 (1.01-1.35)* 
At 6 months 
At 12 months 
1.19 (1.04-1.36)* 
1.16 (1.01-1.33)* 
1.18 (1.03-1.35)* 
1.16 (1.01-1.33)* 
1.23 (1.05-1.43)** 
1.17 (1.00-1.38) 
 
Insulin resistance Model 1 Model 2 Model 3 
 
At baseline 1.04 (0.86-1.27) 1.04 (0.85-1.26) 0.97 (0.80-1.18) 
At 6 months 
At 12 months 
1.20 (1.01-1.42)* 
1.40 (1.16-1.70)** 
1.22 (1.03-1.45)* 
1.41 (1.16-1.72)** 
1.24 (1.02-1.50)* 
1.41 (1.11-1.79)** 
 
HbA1c % Model 1 Model 2 Model 3 
    
At baseline 1.15 (1.02-1.31)* 1.15 (1.01-1.30)* 1.14 (0.99-1.30) 
At 6 months 1.17 (1.03-1.33)* 1.17 (1.03-1.34)* 1.18 (1.03-1.36)* 
At 12 months 1.17 (1.02-1.35)* 1.17 (1.01-1.34)* 1.14 (0.98-1.33) 
    
 
Data are presented as odds ratio (95% confidence interval). 
* p < 0.05; **p < 0.01; ***p < 0.001. 
Model 1: unadjusted; 
Model 2: adjusted for age and gender, as appropriate; 
Model 3: further adjusted for lipid and hypertension medication, number of diabetes 
mellitus medications, sleep dysfunction, physical activity, shift-work, intervention 
type (usual care [referent], diet, diet and physical activity), and BMI, as appropriate. 
At six and 12 months post-intervention, we also adjusted for changes in BMI, waist 
circumference, HOMA-IR and HbA1c from baseline to the corresponding time point, 
as appropriate.  
Obesity defined as BMI ≥30 kg/m2; central adiposity defined as 88 cm (women), 102 
cm (men); insulin resistance defined as HOMA-IR >2.5; HbA1c (<6.5% [referent] 
versus ≥6.5%). 
 
